Related references
Note: Only part of the references are listed.The siRNA cocktail targeting VEGF and HER2 inhibition on the proliferation and induced apoptosis of gastric cancer cell
Kun Liu et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2014)
Myeloid-derived suppressor cells: the dark knight or the joker in viral infections?
Celeste Goh et al.
IMMUNOLOGICAL REVIEWS (2013)
Enhanced activation of human dendritic cells by silencing SOCS1 and activating TLRs simultaneously
Jing Zhang et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
Functional study of immature dendritic cells co-transfected with IL-10 and TGF-beta 1 genes in vitro
Lihong Chen et al.
MOLECULAR BIOLOGY REPORTS (2012)
Blocking the immunosuppressive axis with small interfering RNA targeting interleukin (IL)-10 receptor enhances dendritic cell-based vaccine potency
J. H. Kim et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2011)
The targeted delivery of multicomponent cargos to cancer cells by nanoporous particle-supported lipid bilayers
Carlee E. Ashley et al.
NATURE MATERIALS (2011)
Enhancement of DC vaccine potency by activating the PI3K/AKT pathway with a small interfering RNA targeting PTEN
Jin Hee Kim et al.
IMMUNOLOGY LETTERS (2010)
IRAK-M Removal Counteracts Dendritic Cell Vaccine Deficits in Migration and Longevity
Meghan E. Turnis et al.
JOURNAL OF IMMUNOLOGY (2010)
Leveraging therapeutic potential of multi-targeted siRNA inhibitors
Qing Ge et al.
FUTURE MEDICINAL CHEMISTRY (2009)
Enhancement of dendritic cell-based vaccine potency by anti-apoptotic siRNAs targeting key pro-apoptotic proteins in cytotoxic CD8+ T cell-mediated cell death
Jin Hee Kim et al.
IMMUNOLOGY LETTERS (2009)
Dysfunctional DC subsets in RCC patients: Ex vivo correction to yield an effective anti-cancer vaccine
M. Gigante et al.
MOLECULAR IMMUNOLOGY (2009)
Inefficient presentation of tumor-derived antigen by tumor-infiltrating dendritic cells
Patrizia Stoitzner et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
The role of vascular cell adhesion molecule-1 in tumor immune evasion
T-C. Wu
CANCER RESEARCH (2007)
DC-based cancer vaccines
Eli Gilboa
JOURNAL OF CLINICAL INVESTIGATION (2007)
Enhancing dendritic cell vaccine potency by combining a BAK/BAX siRNA-mediated antiapoptotic strategy to prolong dendritic cell life with an intracellular strategy to target antigen to lysosomal compartments
Tae Heung Kang et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Dendritic cells infiltrating human non-small cell lung cancer are blocked at immature stage
Ivan Perrot et al.
JOURNAL OF IMMUNOLOGY (2007)
Targeting the mechanisms of tumoral immune tolerance with small-molecule inhibitors
Alexander J. Muller et al.
NATURE REVIEWS CANCER (2006)
p38-MAP kinase activation followed by BIM induction is essential for glucocorticoid-induced apoptosis in lymphoblastic leukemia cells
Jianghua Lu et al.
FEBS LETTERS (2006)
Evidence that Ser87 of BimEL is phosphorylated by Akt and regulates BimEL apoptotic function
XJ Qi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Transforming growth factor-β1 immobilises dendritic cells within skin tumours and facilitates tumour escape from the immune system
F Weber et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2005)
Immunosuppressive networks in the tumour environment and their therapeutic relevance
WP Zou
NATURE REVIEWS CANCER (2005)
Dendritic cells as therapeutic vaccines against cancer
J Banchereau et al.
NATURE REVIEWS IMMUNOLOGY (2005)
Dendritic cell immunotherapy: mapping the way
CG Figdor et al.
NATURE MEDICINE (2004)
Mechanisms and functional significance of tumour-induced dendritic-cell defects
D Gabrilovich
NATURE REVIEWS IMMUNOLOGY (2004)
The role of SHIP1 in macrophage programming and activation
MJ Rauh et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2004)
Phosphorylation of Bim-EL by Erk1/2 on serine 69 promotes its degradation via the proteasome pathway and regulates its proapoptotic function
F Luciano et al.
ONCOGENE (2003)
Enhancing DNA vaccine potency by coadministration of DNA encoding antiapoptotic proteins
TW Kim et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Activation of the ERK1/2 signaling pathway promotes phosphorylation and proteasome-dependent degradation of the BH3-only protein, Bim
R Ley et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Reversal of tumor-induced immunosuppression by TGF-β inhibitors
S Wojtowicz-Praga
INVESTIGATIONAL NEW DRUGS (2003)
Suppressors of cytokine signaling and immunity
M Kubo et al.
NATURE IMMUNOLOGY (2003)
Transforming growth factor-β produced by progressor tumors inhibits, while IL-10 produced by regressor tumors enhances, Langerhans cell migration from skin
GM Halliday et al.
INTERNATIONAL IMMUNOLOGY (2001)
RNAi: Double-stranded RNA directs the ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervals
PD Zamore et al.
CELL (2000)
TGF-beta 1 reciprocally controls chemotaxis of human peripheral blood monocyte-derived dendritic cells via chemokine receptors
K Sato et al.
JOURNAL OF IMMUNOLOGY (2000)
Share Paper
